Because the microdialysate is completely free of protein and other biological debris, MD is able to deliver a clean matrix for measurement to a biosensor. Electrochemical detectors were used most frequently for in vivo glucose monitoring 5, [8] [9] [10] and also with the microdialysis sampling. 7, 11 However, even after dialysis, samples encountered under in vivo conditions were reported to poison the electrodes' sensing surface fairly rapidly. Chemiluminescence (CL) detection is now used for a wide range of quantitative applications and offers the advantages of low detection limits, wide linear dynamic range and rapid response with simple instrumentation. 12, 13 There are four reports using CL detection for monitoring of glucose with MD sampling. [14] [15] [16] [17] Naslund et al. 14 used an off-line batch procedure for the measurements for 15 min, but the system is not on-line monitoring one; Fang et al. 15 reported a CL system for in vivo on-line monitoring glucose; however, the system is very complex. In our group, Li et al. 16 has reported a CL flow sensor for in vivo online monitoring of glucose in blood by MD sampling and co-immobilized horseradish peroxidase (HRP) and glucose oxidase (GOD) on the inside surface of the CL flow cell. Wang et al. 17 reported a method based on pre-capillary derivatization with luminol for carbohydrate analysis using capillary electrophoresis with on-line chemiluminescence (CL) detection. The format had been used in determination of glucose in a rat brain with dialysis sampling. But the derivatization of the carbohydrate needs 3 h and the determination is not in vivo.
Nowadays micro-flow injection systems have been used in many fields. 18, 19 Compared with the conventional flow injection system, the sampling volume and the volume of the flow cell of the micro-flow CL system are small. 20, 21 It often has a microinjection valve for controlling the sampling volume. In this work, we used a capillary with the diameter of about 30 µm to form the microdroplet sample. The volume of each droplet is 4.5 µl and the droplet dropped into the flow cell (0.15 ml) to react with the reagent. This format was very simple and easy to fabricate. The sol-gel method is very efficient for retaining the activity of HRP 22 and is considered to be a good way of immobilizing GOD. 23 In this work, the HRP and GOD were coimmobilized with sol-gel method on PMMA plate as the microflow CL cell. The microchannel was fabricated in a polymethyl methacrylate (PMMA) plate using CO2 laser ablation. A droplet-based micro-flow chemiluminescence system with microdialysis sampling has been successfully applied to the online in vivo determination of glucose in the rabbit blood.
Experimental

Materials
All chemicals were of analytical reagent grade; doubly distilled water was used for the preparation of solutions. The Ringer's solution containing 148 mM NaCl, 4.0 mM KCl, and 2.3 mM CaCl2 used as perfusion medium was prepared by dissolving 8.65 g of NaCl, 0.30 g of KCl, and 0.26 g of CaCl2 in 1 L water. A 0.01 M luminol solution was prepared by dissolving 1.7720 g of luminol (Kangpei Technology Co., China, 98%) and 4 g NaOH (Xi'an Chemical Reagent Co., China) in 1000 ml distilled water. 12500 IU heparin sodium injection (Xuzhou First Biological Works, Xuzhou, China) was diluted to 5000 IU using physiological salt solution. A phosphate buffer was used to control pH. Aqueous glucose standards in the range of 0.8 -10 mM were prepared by sequential dilution of a stock solution containing 50 mM glucose with Ringer's solution. HRP (500 U mg -1 ) was purchased from Roche. Glucose oxidase was obtained from Sigma. Tetraethyl orthosilicate (TEOS) was purchased from Xi'an Chemical Reagent Co., China.
Instrumentation
Microdialysis sampling was performed using a syringe pump (Baoding Longer Precision Pump Co., Ltd) coupled to a MD-2310 microdialysis probe from Bioanalytical System (BAS) (West Lafayette, IN). The syringe pump was used for delivery of perfusate. PTFE tubing (0.2 mm i.d.) was used for connected the perfusate with a capillary and for the waste. With the syringe pump, a microdroplet of 4.5 µl was formed at the tip of the capillary. The chemiluminescence reagent was pumped by another syringe pump into the round flow cell through the microchannel in the plate. The sample microdroplet dropped into the flow cell which co-immobilized HRP and GOD on the bottom surface and mixed with luminol to produce chemiluminescence. The CL signal was detected and recorded with a computerized Ultra-weak Luminescence Analyzer (Type BPCL, manufactured at the Institute of Biophysics, Academia Sinica, China). Date acquisition and treatment were performed with BPCL software running under Windows 2000.
Fabrication of the micro-flow chemiluminescence system
The micro-flow CL system shown in Fig. 2 was composed of a capillary and a three-plate integrated flow cell with the microchannels. The matrix of the three plates was polymethyl methacrylate (PMMA). The upper plate (50 × 40 × 5 mm) had two drilled holes (Fig. 2) . The hole (f, 0.3 mm i.d.) was connected with the syringe pump and the microchannel in the middle plate, and another hole (h) with the diameter of 8 mm was against the flume in the middle plate. The microchannel (width: 200 µm, depth: 100 µm, length: 15 mm) fabricated by CO2 laser ablation in the surface of the middle plate was on the left side of the flume. The distance with the lowest point of the flume to the surface was 3 mm. At the lowest point we drilled a hole with the diameter of 0.2 mm. The hole connected the microchannel in the bottom plate (width: 300 µm, depth: 100 µm, length: 22 mm). Finally, the three plates were bonded together by heating at 108˚C for 10 min with 1.5 MPa pressure. A schematic diagram of the section of the three plates is shown in Fig. 2B . After bonding the three plates, we inserted the capillary into a plastic conical tube, which was shown in Fig.  2A . The capillary was made by drawing a glass tube with the diameter of 0.2 mm. The diameter of 0.2 mm of one end of the capillary coincided with that of the connector of the plastic conical tube. We sealed the exterior of the connector with epoxy. The other end of the capillary with the diameter of about 30 µm was above the upper plate. The distance to the surface of the upper plate was 2 mm, as was shown in Fig. 2B . The diameter of the bottom side of the plastic conical tube was the same as the diameter of the flow cell hole in the upper plate in Fig. 2A . It was carefully made to coincide with the hole and was sealed with epoxy around it.
Preparation of HRP and GOD encapsulated sol-gel membrane
The preparation procedure of the sol-gel stock solution was similar to that proposed by Parang et al. 24 TEOS (2.2 ml), H2O (0.7 ml) and 0.1 M HCl (50 ml) were mixed in a glass vial. The mixture was stirred for 3 h and then a clear sol-gel stock solution was obtained. The stock solution was stored in a refrigerator at 4˚C. The HRP solution was prepared by dissolving 1 mg HRP and 500 U GOD in 0.25 ml phosphate buffer (pH 6.0). Then, 0.1 ml sol-gel working solution, 0.1 ml HRP and GOD solution were mixed. After bonding the three plates, we inserted a hypodermic needle with the diameter of 0.2 mm into the drilled hole at the lowest point of the flume. Then we dropped one drop (50 µl) of the mixture into the flume. We gingerly put up the right side of the plates a little for the mixture to polymerize a gel more easily. By the spreading method, the drop of the mixture was coated on the PMMA surface, and then was allowed to polymerize and become a gel at room temperature for about 30 min. When the mixture was about to be a gel we carefully took the hypodermic needle out, so the drilled hole cannot be jammed with the gel. Finally, the plastic 414 ANALYTICAL SCIENCES APRIL 2005, VOL. 21 conical tube which had been inserted a capillary was carefully coincided with the hole as the flow cell and was sealed with the epoxy around it.
In vitro experiments
In these experiments, aqueous standard solutions were used instead of real samples from test animals. The calibration of the measurement was performed by a probe in the Ringer's solution with glucose concentration of 0, 0.8, 1, 2, 4, 6, 8, 10 mM, which changed incrementally. The syringe with the microdialysis probe was set at 6 µl/min. After an equilibration time of 30 min, one dialysis sample was collected every 3 min (135 s loading time and 45 s injection time). Perfusate (4.5 µl) was formed a drop at the capillary tip. Then the drop fell into the flow cell which co-immobilized HRP and GOD and mixed luminol stream from the microchannel to produce a CL signal. The CL signal was detected and recorded.
In vivo experiments
Rabbits weighing ∼3.0 kg were used in all in vivo experiments without anesthetization. Movement of the test animal was limited by fixing it on a wooden chassis. About 20 min before the experiments, the rabbit was given an intravenous injection of 5000 IU of heparin sodium injection via the edge vein of the test animal's ear to avoid clogging by blood coagulation during the experiments. A sterilized stainless-steel needle was inserted into a split guide, then inserting most of the unsplit portion of the split guide into the jugular, one slowly removes the insertion needle from the split guide. When the needle is out, the MD probe is slipped into the split guide, the probe is inserted deeply enough to ensure that the MD membrane is fully inserted in the lumen of the jugular. The point of insert was taped onto the skin of the animal. Then the MD sampling in blood was perfusing the probe with Ringer's solution at a rate of 6 µl/min. Further operation of CL measurement was followed and is described in the previous paragraph. The glucose content in the perfusates was monitored with continuous sampling. We recorded the CL signal after achieving a stable signal.
Results and Discussion
Optimization of the CL detection system
As the luminescence reagent, luminol concentration affects the micro-flow CL system response. The effect of luminol concentration was investigated in the range of 1 × 10 -4 -5 × 10 -3 mol/l, which is shown in Fig. 3 . From Fig. 3 we can see that an increase in the CL intensity with an increase in luminol concentration. But when the concentration of luminol was bigger than 1 × 10 -3 mol/l, the CL intensity decreased slowly and the precision is poor.
So we chose the optimal concentration of luminol to be 1 × 10 -3 mol/l. In this micro-flow CL system, the pH of the luminol solution is medium of enzyme and also is medium of the CL reaction. There are two factors which determine the overall response in this micro-flow system: the influence of pH on the enzyme activity and the effect of pH on the generated CL signal. The optimal pH value for HRP and GOD is 6 -7. However, the CL reaction between luminol and H2O2 shows the maximum CL intensity at pH 10 -11. 25 So the effect of medium pH on the micro-flow CL system was investigated. In this experiment, because the sample volume is 4.5 µl, the pH of luminol solution is the real pH in the micro-flow cell. The result (Fig. 4) showed that optimal pH was 9.0. Therefore, the micro-flow system was operated at pH 9.0 using phosphate buffer solution throughout this study.
The stability of the immobilized HRP and GOD reaction is particularly important in continuous monitoring. So, the stability of the immobilized enzyme in the flow cell was examined under in vitro conditions by repetitive injection of 0.5 mM glucose standard solution for 2 h at a frequency of 20 h -1 , using both a new micro-flow cell and one already used for 10 h. The leaking rate of HRP and GOD from the sol-gel membrane affects the stability of the enzyme reactor. The CL intensity of the newly prepared sol-gel membrane was compared with that of the same membrane already used for 10 h, and no obvious decrease of the signal (decreased by about 10%) was observed. Because large quantities of hydroxyl group in the sol-gel hybrid material can form strong hydrogen bonds to prevent the enzyme from leaking out of the thin film, we can use it for 10 h. The MD recovery depends on the perfusion rate, 26 so the perfusion rate has an effect on the CL intensity. The effect of the perfusion rate (1 -10 µl/min) was investigated. The results (Fig. 5) showed a significant decrease in the CL intensity with an increase in perfusion rate. The reason is that the recovery decreases with increase in the perfusion rate. But if the perfusion rate was too low, forming a sampling drop needed several minutes. So considering the sensitivity and analysis efficiency, 6.0 µl/min was selected as the perfusion rate and so the sample throughput was 20 h -1 .
In the micro-flow CL system, the mixing and reaction time was fast. So we must select a proper flow rate for the sufficient mixing of the solvents and to assure that the CL intensity was high. The reagent of luminol was connected with another syringe pump. We chose the flow rate from 0.02 ml/min to 0.2 ml/min. From the CL intensity, we select the flow rate of 0.08 ml/min with the high CL intensity and proper mixing of the solvents in Fig. 6 . If the flow rate was fast, the sample cannot mix sufficiently with the reagent and the enzyme in the sol-gel film. If the flow rate was slow, the detection time was long and this led to a wide peak of the CL intensity.
Interference studies
In order to determine glucose in the blood, we investigated the interference of the common ions and excipients in blood for the 415 ANALYTICAL SCIENCES APRIL 2005, VOL. 21 determination of 1 × 10 -4 mol/l glucose. The tolerable concentration ratios for interference at the 5% level were over 500 for Na
, NO 3-, SO4 2- , 100 for urea, lactic acid, 50 for uric acid. 1 × 10 -4 mol/l ascorbic acid negatively interfered because ascorbic acid can easily reduce hydrogen peroxide produced from the enzymatic reaction. But the concentration of ascorbic acid in blood is smaller than that of glucose in blood. The results showed that the proposed method has good selectivity; only ascorbic acid caused interference.
Performance of the on-line MD CL system
In vitro experiments. In Fang's work, 15 the sample loop was only partially filled. But in our work, the sample volume was 4.5 µl with the perfusion rate of 6 µl/min and we do not need a sample loop. The syringe pump with the MD probe was opened for 45 s every 3 min. The sample formed a drop and dropped into the flow cell to produce CL. Calibration graphs were linear in the range of 0.8 -10 mM glucose expressed by the regression equation: I = 5.7C + 80.7, R = 0.9961 (n = 5), I being the relative CL intensity and C the glucose concentration (mM). The detection limit based on three times the baseline noise was 0.1 mM. The relative deviation was 2.9% for 5 mM glucose (n = 11). In vivo experiments. Under the system in Fig. 1 , the in vivo determination of glucose in the jugular veins of rabbits was carried out. The glucose concentration in the blood was monitored by continuous sampling after it reached a stable signal. Compensation for variation of sensitivity during in vivo monitoring was performed similarly by the equation proposed by Fang et al. 15 The results are given in Table 1 .
The micro-flow CL system developed in this work demonstrated considerable potentials for in vivo on-line monitoring of glucose rabbits using relatively simple instrumentation. Moreover, the system can be readily adapted to other analytes (such as uric acid, lactate) by varying the enzyme reactor. 
